SMDG is led by an international team whose expertise spans disease biology, neuroscience, nanomedicine, drug delivery, chemistry, clinical medicine, medical affairs, biotechnology development, business strategy and patient advocacy. Together, our leadership, Board and advisory groups guide the scientific, strategic and translational development of our proprietary platforms and therapeutic programs.